Beta-blockers for suspected or diagnosed acute myocardial infarction

To assess the benefits and harms of beta-blockers for patients with suspected or diagnosed acute myocardial infarction compared with placebo or no intervention at one-month follow-up, and at maximum follow-up.

This is a protocol.

Share/Save